| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1921323 | Parkinsonism & Related Disorders | 2009 | 4 Pages |
Abstract
Non-ergot dopamine receptor agonists, such as ropinirole, pramipexole, rotigotine and apomorphine, may alleviate some non-motor symptoms in Parkinson's disease (PD) while others may be precipitated. In this review, we discuss how dopamine receptor agonists can both ameliorate and aggravate the sleep problems in PD, a key non-motor symptom of this disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
K. Ray Chaudhuri, Kartik Logishetty,